M. Rodríguez‐Torres
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 114
- Hepatitis C virus research 112
- Epidemiology 87
- Hepatitis B Virus Studies 60
- Liver Disease Diagnosis and Treatment 56
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Co-authors
- Eric LawitzStefan ZeuzemHendrik W. ReesinkMichael R. HodgesKeyur PatelRozanne C. de VeerYi ZhouAlice P. Chen
- Journals
- Journal of Hepatology (57 papers)Hepatology (12 papers)Gastroenterology (10 papers)HIV Clinical Trials (5 papers)Journal of Viral Hepatitis (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
M. Rodríguez‐Torres
145 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hepatology 4.7k
- Epidemiology 4.2k
- Cancer Research 1.3k
- Infectious Diseases 1.5k
- Virology 215
Countries citing papers authored by M. Rodríguez‐Torres
This map shows the geographic impact of M. Rodríguez‐Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rodríguez‐Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rodríguez‐Torres more than expected).
Fields of papers citing papers by M. Rodríguez‐Torres
This network shows the impact of papers produced by M. Rodríguez‐Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rodríguez‐Torres. The network helps show where M. Rodríguez‐Torres may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Rodríguez‐Torres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 37 | |
| 2 | 2013 | 1 | |
| 3 | 2013 | 111 | |
| 4 | 2012 | 2 | |
| 5 | 2012 | 46 | |
| 6 | 2012 | 3 | |
| 7 | FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA | 2011 | 12 |
| 8 | 2010 | 5 | |
| 9 | 2010 | 18 | |
| 10 | 2010 | 26 | |
| 11 | 2010 | 6 | |
| 12 | 2010 | 25 | |
| 13 | 2009 | 66 | |
| 14 | 2009 | 134 | |
| 15 | Double blind, randomized, placebo-controlled, multi-center,phase II dose ranging study to assess the antifibrotic activityof farglitazar in chronic hepatitis C infection. | 2008 | 2 |
| 16 | 2008 | 6 | |
| 17 | 2008 | 29 | |
| 18 | 2007 | 84 | |
| 19 | 2006 | 25 | |
| 20 | 2004 | 15 |
About M. Rodríguez‐Torres
M. Rodríguez‐Torres is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Genetics and Virology, having authored 148 papers that have together received 7.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (112 papers), Hepatitis B Virus Studies (60 papers), Liver Disease Diagnosis and Treatment (56 papers), HIV/AIDS drug development and treatment (31 papers), Chronic Lymphocytic Leukemia Research (14 papers), Immunodeficiency and Autoimmune Disorders (12 papers), Systemic Lupus Erythematosus Research (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). The work is most often cited by research in Hepatology (4.7k citations), Epidemiology (4.2k citations), Cancer Research (1.3k citations), Infectious Diseases (1.5k citations) and Virology (215 citations). M. Rodríguez‐Torres has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Eric Lawitz, Stefan Zeuzem, Hendrik W. Reesink, Michael R. Hodges, Keyur Patel, Rozanne C. de Veer, Yi Zhou, Alice P. Chen, Robert Persson and Arthur A. Levin. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, HIV Clinical Trials and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.